Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

Data from the CEPHEUS trial support the use of D-VRd in patients with transplant-ineligible or -deferred multiple myeloma who can tolerate bortezomib. Adding daratumumab (Darzalex) to bortezomib ...

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...

You’re looking at the new MG S5 EV, yet another new challenger in the increasingly busy B-segment SUV market and the fifth EV from the brand. It’ll ride on the same Modular Scalable Platform ...

MG Motor India’s Windsor EV has become the best-selling electric vehicle in the country with over 15,000 units sold. Its success is due to competitive pricing, innovative features, and the ...

Join 1000s of buyers using the power of Australia's leading new car destination to save time, money and stress. Find a deal The MG 5 is Australia’s cheapest sedan – that’s one way of looking at it.

Speaker] The cardinal. - He's the perfect mark. - [Speaker 2] Some close to you do not wish you well. - If you know something, tell me. - [Speaker 2] Just be careful, Antoinette. - [Marie] I'm not ...

Rybelsus ® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial 1.

IM Motors will debut in Australia as IM Presented by MG with high-performance EVs ... The IM5 sedan can reportedly hit 100 km/h (62 mph) in just 2.74 seconds, while the SUV needs 3.48 seconds.

The company claims it is the fastest MG Roadster ever and it just set a record at Sambhar Salt Lake in Rajasthan accelerating to 100 km/h in just 3.2 seconds. It is a 2-door convertible Roadster ...

Overall mortality was 9%, with 97.2% of deaths occurring within 30 days of hospitalisation. The adjusted 30-day death rate was 6% in the dexamethasone group vs 12% in the no dexamethasone group ...